课题基金 / 基金详情

Development of a new sense oligonucleotide drug targeting inducible nitric oxide synthase for sepsis model rats

Development of a new sense oligonucleotide drug targeting inducible nitric oxide synthase for sepsis model rats
脓毒症模型大鼠靶向诱导型一氧化氮合酶的新型寡核苷酸药物的研制
批准号:
19K18370
负责人:
NAKATAKE Richi
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2019
资助国家:
日本
项目状态:
已结题
起止时间:
2019-04-01 至 2021-03-31

项目摘要

项目成果

NAKATAKE Richi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Protective effect of the proton pump inhibitor lansoprazole in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
质子泵抑制剂兰索拉唑对 D-半乳糖胺和脂多糖诱导的致死性急性肝衰竭大鼠的保护作用。
DOI: --
发表时间: 2020
期刊:
影响因子: --
作者: [Richi Nakatake, Hidehiko Hishikawa , Masaya Kotsuka , Katsuhiko Yoshizawa, Mikio Nishizawa, Tadayoshi Okumura , Rene H. Tolba and Mitsugu Sekimoto]
通讯作者: Rene H. Tolba and Mitsugu Sekimoto
The protective effects of a sense oligonucleotide drug targeting inducible nitric oxide synthase for a rat model of acute liver injury.
靶向诱导型一氧化氮合酶的正义寡核苷酸药物对急性肝损伤大鼠模型的保护作用。
DOI: --
发表时间: 2020
期刊:
影响因子: --
作者: [Richi Nakatake, Tetsuya Okuyama, Masaki Kaibori, Tadayoshi Okumura, Mitsugu Sekimoto, Rene H. Tolba and Mikio Nishizawa.]
通讯作者: Rene H. Tolba and Mikio Nishizawa.
Essential amino acid tryptophan has a liver-protective effect through the suppression of inducible nitric oxide synthase in primary cultured rat hepatocytes.
必需氨基酸色氨酸通过抑制原代培养的大鼠肝细胞中的诱导型一氧化氮合酶而具有肝脏保护作用。
DOI: --
发表时间: 2019
期刊:
影响因子: --
作者: [Richi Nakatake, Takumi Tsuda, Hirokazu Miki, Tatsuma Sakaguchi,Masaya Kotsuka, Masaki Kaibori, Tadayoshi Okumura, Mikio Nishizawa, and Mitsugu Sekimoto.]
通讯作者: and Mitsugu Sekimoto.
Active Hexose Correlated Compound Has Protective Effects in Ischemia?Reperfusion Injury of the Rat Small Intestine
活性己糖相关化合物对大鼠小肠缺血再灌注损伤的保护作用
DOI: 10.1016/j.jss.2019.05.047
发表时间: 2019
期刊: Journal of Surgical Research
影响因子: 2.2
作者: [Ueyama Yosuke, Tokuhara Katsuji, Miki Hirokazu, Nakatake Richi, Sakaguchi Tatsuma, Nishizawa Mikio, Kaibori Masaki, Okumura Tadayoshi]
通讯作者: Okumura Tadayoshi
13
    A therapeutic strategy for human hepatocellular carcinoma using "armed" oncolytic herpes simplex viruses.
    • 批准号:
      17K18252
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.83万
    • 财政年份:
      2017
    • 负责人:
      NAKATAKE Richi
    • 依托单位:
    海外基金